When Zepbound (Tirzepatide) is taken with insulin and the insulin dose is reduced too quickly, it can lead to high blood sugar (hyperglycemia), which increases the risk of diabetic ketoacidosis
Site rotation lowers repeated irritation Approved GLP1 injection sites are the abdomen at least 2 inches from the navel, the front or outer thigh, and the back or outer upper arm
This is a typical picture for the entire class of regenerative peptides: a strong signal from preclinical models (rodents, cell cultures), without full phase III clinical confirmation
It supports relief from nerve-related pain, discomfort, and hypersensitivity
1 dose (2 sprays) is 100 mg total
The reverse switch from tirzepatide to semaglutide is less common but occasionally necessary, usually due to insurance coverage or cost considerations